Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer : Results of Cancer and Leukemia Group B 99811

✍ Scribed by William Kevin Kelly; Susan Halabi; Aymen Elfiky; San-San Ou; Jeff Bogart; Michael Zelefsky; Eric Small

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 138 KB
• Volume: 113
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.23910